Arbaclofen Extended-Release for Spasticity in Multiple Sclerosis: Responder Analysis of a Phase 3 Randomized, Placebo-Controlled Clinical Study OS440-3004
Background: Arbaclofen is the active R-enantiomer of racemic baclofen. Arbaclofen extended-release (ER) tablets have demonstrated efficacy...
Identifying and Characterizing Fatigue in Patients Diagnosed with Multiple Sclerosis on Disease-Modifying Therapies Using Real World Evidence
Background: Fatigue is a common symptom in patients with Multiple Sclerosis (MS). Payor databases represent an important source of real...
Difference in Lower Limb Strength Asymmetry between Fallers and Non-Fallers with Multiple Sclerosis
Background: Lower limb (LL) asymmetry in persons with multiple sclerosis (PwMS) has been associated with decreased balance and abnormal...
Is Depression Associated with Volume and Pattern of Sedentary Behavior in Persons with Multiple Sclerosis?
Background: Depression is highly prevalent and influences physical function and mobility disability in persons with MS. There are data...
A Review of Participant Characteristics in Theory-Based Physical Activity Behavior Change Programs in MS: Missing the Greatest Potential for Lifelong Benefits
Background: Physical activity may be beneficial for people with multiple sclerosis (MS), but this population is still physically inactive...
Characterizing the Relationship between Neurological/Mental Health and Physical Activity Levels in Persons with Multiple Sclerosis
Background: Physical activity is one way that persons with multiple sclerosis (MS) (PwMS) can manage disease symptoms and progression....
Assessing the Benefits of Using Telehealth in Conjunction with a Fitbit to Improve Walking in Veterans with Multiple Sclerosis
Background: Patients with multiple sclerosis often have limitations with mobility due to fatigue, weakness, and impairments with balance...
Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) may experience acute relapses that are nonresponsive (20-35%) to...